This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 3 EPO patents. Top assignee: Digna Biotech, S.l.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of Vladas Algirdas Bumelis
Introduction
Vladas Algirdas Bumelis is a notable inventor based in Vilnius, Lithuania. He has made significant contributions to the field of biotechnology, particularly in the production of interferon alpha 5. His work has implications for medical research and therapeutic applications.
Latest Patents
Bumelis holds a patent for a method of producing interferon alpha 5. This process involves expressing the IFNa5 protein in a host cell while minimizing the incorporation of an extra methionine residue at the N-terminal end of the polypeptide chain. The patent also addresses the generation of oxidized species and outlines an efficient purification process to yield biologically active IFNa5.
Career Highlights
Throughout his career, Bumelis has worked with various companies, including Digna Biotech and UAB Biotechnologines Farmacijos Centras, also known as Biotechpharma. His experience in these organizations has contributed to his expertise in biotechnology and patent development.
Collaborations
Bumelis has collaborated with notable colleagues such as Saule Sudziuviene and Nerijus Makauskas. Their joint efforts have likely enhanced the research and development processes in their respective projects.
Conclusion
Vladas Algirdas Bumelis is a distinguished inventor whose work in biotechnology, particularly in the production of interferon alpha 5, showcases his innovative spirit and dedication to advancing medical science. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile